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We reviewed “Opioid Analgesia for Medical Abortion: A Randomized 
Controlled Trial” with significant interest to inform us as providers as well as 
our patients (1). The study aimed to examine the effectiveness of opioids for 
pain relief during medical abortion, a question studied by one prior clinical 
trial which compared ibuprofen and acetaminophen-codeine (2). Colwill et al 
claimed the conclusions of this prior study were “limited by underdosing of a 
weak opioid;” accordingly, they designed their study using a “strong opioid” 
targeting the “severe pain” of medical abortion (1). The study regimen 
included oxycodone10-mg orally or placebo at the onset of uterine cramping 
with ibuprofen 800 mg (#9) and a prescription for oxycodone 5-mg tablets 
every 4 hours as needed for pain (#6). This trial found that the women 
experienced severe pain with peak levels lasting approximately 1 hour and 
no difference in maximal pain between the oxycodone and placebo groups.
The design and conclusions of their study fail to recognize the clinical 
distinction between acute and sub-acute pain. While oxycodone 5-10 mg 
every 4 hours is commonly used for sub-acute or chronic pain control, this is 
not routine management for severe acute pain.  In this study, the most 
analgesia women received over one hour of acute pain was oxycodone 10 
mg, equivalent to morphine sulfate 5 mg IV or IM. As a comparison, we 
provide term patients with contractions but not in labor morphine sulfate 10 
mg IM just to go home and rest.  Thus, this regimen is simply inadequate for 
acute pain. 
We applaud the researchers for measuring the amount of pain that 
women experience acutely with medical abortion. We urge clinicians to 
provide adequate dosing of narcotics as would be given to any patient in an 
emergency room in an acute setting.  Appropriate dosing would allow 
patients to use at least twice that dose for acute pain. We do not agree that 
this study demonstrates that narcotics are no better than placebo but, 
rather, that we are inadequately treating the acute pain that women can 
experience with medical abortion. 
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